Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
Andres J YarurMichael V ChioreanJulian PanesVipul JairathJinkun ZhangChristopher J RabbatWilliam J SandbornSeverine VermeireLaurent Peyrin-BirouletPublished in: Journal of Crohn's & colitis (2024)
NCT02447302.